1,5-dimethyl-4-imidazolecarbonitril

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1,5-dimethyl-4-imidazolecarbonitril
• 英文别名: 4-cyano-1,5-dimethylimidazole；1,5-dimethyl-1H-imidazole-4-carbonitrile；1,5-dimethylimidazole-4-carbonitrile
• 化学式: C₆H₇N₃
• mdl: MFCD18808600
• 分子量: 121.142
• InChiKey: OXWHKPWTOATYRI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  41.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1,5-二甲基-1H-咪唑-2-甲腈 以 乙腈 为溶剂， 生成 1,5-dimethyl-4-imidazolecarbonitril
  参考文献：
  名称：

  吡唑的光转位中的竞争途径

  摘要：

  氰基取代的吡唑通过两种同时的途径以光化学方式转变为咪唑：（a）1,5-交换，可能通过2,5-结合至二氮杂双环戊烯，该二氮杂双环戊烯在重新芳构化之前通过氮的“游走”而异构化；和（b）2 3-互换，可能是通过中间的叠氮基进行的；与之形成鲜明对比的是，1,5-二甲基-3-三氟甲基吡唑仅通过前者的路径进行光转位。

  DOI：

  10.1039/c39810000604

文献信息

• Anodic Cyanation of 1-Methylimidazoles
  作者：Kunihisa Yoshida、Hirohito Kitabayashi

  DOI：10.1246/bcsj.60.3693

  日期：1987.10

  The electrooxidation of several 1-methylimidazoles was performed in MeOH that contains NaCN at a platinum anode in a divided cell. Replacement of an aromatic hydrogen by a cyano group occurred. With 1,2,4,5-tetramethylimidazole, the 2,5-addition of cyano groups to the imidazole ring was achieved, and besides side-chain substitution occurred concurrently.

  几种 1-甲基咪唑的电氧化在含有 NaCN 的 MeOH 中进行，在分离式电池的铂阳极上进行。芳族氢被氰基取代。使用1,2,4,5-四甲基咪唑，实现了氰基向咪唑环的2,5-加成，并且同时发生侧链取代。
• HETEROCYCLIC CETP INHIBITORS
  申请人：Salvati Mark E.

  公开号：US20120322761A1

  公开（公告）日：2012-12-20

  Compounds of formula Ia and Ib wherein A, B, C and R 1 are described herein.

  其中A，B，C和R1所描述的式子Ia和Ib的化合物。
• [EN] LZK‑TARGETING DEGRADERS AND METHODS OF USE<br/>[FR] AGENTS DE DÉGRADATION CIBLANT LZK ET PROCÉDÉS D'UTILISATION
  申请人：US HEALTH

  公开号：WO2022051326A1

  公开（公告）日：2022-03-10

  Leucine zipper‑bearing kinase (LZK) targeted degraders are disclosed. The compounds have a general formula Q‑L‑Z where Q is an LZK binding moiety, L is a linker, and Z is an E3‑ligase binding moiety. The compounds inhibit LZK activity and/or degrade LZK. The compounds may be used to treat diseases or conditions characterized at least in part by LZK overexpression.

  本文披露了含亮氨酸拉链激酶（LZK）的降解物。这些化合物的一般公式为Q-L-Z，其中Q是LZK结合基团，L是连接剂，Z是E3-连接酶结合基团。这些化合物可抑制LZK的活性和/或降解LZK。这些化合物可用于治疗至少部分由LZK过度表达所特征的疾病或病况。
• BARLTROP, J. A.;DAY, A. C.;MACK, A. G.;SHAHRISA, AZIZ;WAKAMATSU, SHIGERU, J. CHEM. SOC. CHEM. COMMUN., 1981, N 12, 604-606
  作者：BARLTROP, J. A.、DAY, A. C.、MACK, A. G.、SHAHRISA, AZIZ、WAKAMATSU, SHIGERU

  DOI：——

  日期：——
• ORGANIC ELECTROLUMINESCENCE ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE
  申请人：Katakura Rie

  公开号：US20100045171A1

  公开（公告）日：2010-02-25

  Disclosed is an organic electroluminescent device having high external quantum efficiency and long emission life. Also disclosed are an illuminating device and a display, each comprising such an organic electroluminescent device. The organic electroluminescent device is characterized by comprising at least an anode and a cathode on a supporting substrate, while having at least one light-emitting layer between the anode and the cathode. The organic electroluminescent device is also characterized by containing a polymer which at least partially contains a compound A having a partial structure represented by the general formula (a) below and a reactive group, and is obtained by polymerizing the compound A through the reactive group. (In the formula, Ar1 and Ar2 respectively represent an aromatic ring.)